The gut-lung axis in cystic fibrosis

CE Price, GA O'Toole - Journal of bacteriology, 2021 - Am Soc Microbiol
Cystic fibrosis (CF) is a heritable, multiorgan disease that impacts all tissues that normally
express cystic fibrosis transmembrane conductance regulator (CFTR) protein. While the …

Cystic fibrosis–related liver disease: research challenges and future perspectives

D Debray, MR Narkewicz, FAJA Bodewes… - Journal of pediatric …, 2017 - journals.lww.com
Objectives: Hepatobiliary complications are a leading cause of morbidity and mortality in
cystic fibrosis (CF) patients. Knowledge of the underlying pathological aspects and optimal …

[HTML][HTML] Pathophysiology of cystic fibrosis liver disease: a channelopathy leading to alterations in innate immunity and in microbiota

R Fiorotto, M Strazzabosco - Cellular and Molecular Gastroenterology and …, 2019 - Elsevier
Cystic fibrosis (CF) is a monogenic disease caused by mutation of Cftr. CF-associated liver
disease (CFLD) is a common nonpulmonary cause of mortality in CF and accounts for …

Animal models of cystic fibrosis in the era of highly effective modulator therapies

BR Grubb, A Livraghi-Butrico - Current opinion in pharmacology, 2022 - Elsevier
Few human genetic diseases can rely on the availability of as many and as diverse animal
models as cystic fibrosis (CF), a multiorgan syndrome caused by functional absence of cystic …

[PDF][PDF] Diet‐induced dysbiosis and genetic background synergize with cystic fibrosis transmembrane conductance regulator deficiency to promote cholangiopathy in …

D Debray, H El Mourabit, F Merabtene… - Hepatology …, 2018 - Wiley Online Library
The most typical expression of cystic fibrosis (CF)–related liver disease is a cholangiopathy
that can progress to cirrhosis. We aimed to determine the potential impact of environmental …

Clinical effects of probiotics in cystic fibrosis patients: A systematic review

S Van Biervliet, D Declercq, S Somerset - Clinical nutrition ESPEN, 2017 - Elsevier
Cystic fibrosis (CF) is characterised by a build-up of thick, intransient mucus linings of the
digestive and respiratory mucosa, which disrupts digestive system functioning and …

[HTML][HTML] Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis

IP van de Peppel, FAJA Bodewes, HJ Verkade… - Journal of Cystic …, 2019 - Elsevier
With the improved treatment of the pulmonary complications of cystic fibrosis (CF),
gastrointestinal problems have become more important in the morbidity in CF. A hallmark of …

[HTML][HTML] The efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: a clinical observational cohort study

S Poetter-Lang, K Staufer, P Baltzer, D Tamandl… - European …, 2019 - Springer
Purpose To identify independent imaging features and establish a diagnostic algorithm for
diagnosis of cystic fibrosis (CF)-associated liver disease (CFLD) in CF patients compared to …

[HTML][HTML] Impaired intestinal Farnesoid X receptor signaling in cystic fibrosis mice

PT Ikpa, M Doktorova, KF Meijsen… - Cellular and molecular …, 2020 - Elsevier
Background & Aims The bile acid (BA)-activated farnesoid X receptor (FXR) controls hepatic
BA synthesis and cell proliferation via the intestinal hormone fibroblast growth factor 19 …

Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol

A Bertolini, IP van de Peppel… - American Journal …, 2019 - journals.physiology.org
The gastrointestinal phenotype of cystic fibrosis (CF) features intestinal bile acid (BA)
malabsorption, impaired intestinal farnesoid X receptor (FXR) activation, and consequently …